Sodium channel blockers
US8350076B2 · kind B2 · utility
1Cited by
7References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 11, 2008 |
| Grant date | Jan 8, 2013 |
| Priority date | — |
| Expiry date | Oct 18, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/78
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel phenyloin derivative compounds and the use of such compounds as sodium channel blockers. Such compositions have utility as anti-cancer agents and can be used to limit or prevent PCa growth and/or metastasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.